Join to View Full Profile
200 1st St SwRochester, MN 55905
Phone+1 507-284-2511
Dr. Hogan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1998 - 2001- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1995 - 1997
University of Dublin Trinity CollegeClass of 1992
Certifications & Licensure
MN State Medical License 1997 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Start of enrollment: 2004 Dec 01
- Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402) Start of enrollment: 2006 Nov 01
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Join now to see all
Publications & Presentations
PubMed
- Clinical Outcomes and Treatment Strategies of Adult Transplant-Associated Thrombotic Microangiopathy: External Validation of Harmonizing Definitions and High-Risk Crit...Aldo A Acosta-Medina, Meera Sridharan, Ronald S Go, Ann M Moyer, Nelson Leung
American Journal of Hematology. 2025-05-01 - 3 citationsCNS manifestations in acute and chronic graft-versus-host disease.Nicolas Lambert, Florence Forte, Majdouline El Moussaoui, Justine Monseur, Nicole Raus
Brain. 2025-04-03 - Venetoclax in combination with fludarabine, cytarabine, granulocyte colony stimulating factor, and idarubicin (FLAG-Ida) in patients with acute leukemia of ambiguous l...Steven Tessier, Kristen B McCullough, Naseema Gangat, Kebede H Begna, Antoine N Saliba
Leukemia & Lymphoma. 2025-04-01
Journal Articles
- Safety and Efficacy of Propylene Glycol-Free Melphalan as Conditioning in Patients with AL Amyloidosis Undergoing Stem Cell TransplantationNelson Leung, Prashant Kapoor, Taxiarchis V Kourelis, Eli Muchtar, Angela Dispenzieri, M Hasib Sidiqi, Martha Q Lacy, Wilson I Gonsalves, Shaji K Kumar, Mohammed A Alj..., Nature
- Comparable Outcomes Using Propylene Glycol-Free Melphalan for Autologous Stem Cell Transplantation in Multiple MyelomaMorie A Gertz, Shaji K Kumar, Martha Q Lacy, Prashant Kapoor, Suzanne R Hayman, Robert C Wolf, William J Hogan, Wilson I Gonsalves, Angela A Dispenzieri, David Dingli,..., Nature
- Does Matching for SNPs in the MHC Gamma Block in 10/10 HLA-Matched Unrelated Donor-Recipient Pairs Undergoing Allogeneic Stem Cell Transplant Improve Outcomes?Eapen K Jacob, Shahrukh K Hashmi, Justin D Kreuter, William J Hogan, Dennis A Gastineau, Ann M Moyer, Mark Litzow, ScienceDirect
- Join now to see all
Press Mentions
Expert Alert: Five Key Medical Advances Related to Bone Marrow TransplantationOctober 11th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
